New Law Could Bring Surge in Clinical Trials to Brazil
Companies could find Brazil a more attractive place to conduct clinical trials thanks advances in digital healthcare and a new law that will cut bureaucracy and shorten approval timelines for trials.
You may also be interested in...
Industry access to real world data for regulatory and market access purposes in Asia Pacific compares poorly with the US.
Draft guidelines due out for consultation this week in Italy are expected to shed more light on what companies will have to reveal during pricing and reimbursement negotiations.
Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in a move towards increasing biosimilar uptake.